Market Review

At the end of 2012, the annual value of the global pharmaceutical market was about EUR 900 billion. Oriola-KD operates on pharmaceutical markets with an annual value of about EUR 6.5 billion* **. The Swedish market is valued at about EUR 3.5 billion and the Finnish market at about EUR 2 billion. The Estonian, Latvian and Lithuanian markets combined are valued at about EUR 1 billion.

 

In all its markets, Oriola-KD’s pharmaceutical wholesale business operates under the Oriola brand. Oriola-KD is the second largest operator on the Finnish and Swedish markets. Oriola-KD's market share of the Finnish pharmaceutical wholesale market was about 46 per cent (source: ATY), while in Sweden Oriola-KD estimates that its market share in the wholesale trade was about 38 per cent at the end of September 2014.

 

Oriola-KD engages in retail operations in Sweden and owns the Kronans Apotek pharmacy chain. Oriola-KD is the third largest operator in Sweden and the company estimates that its market share was about 21 per cent at the end of September 2014. Oriola-KD had 303 pharmacies in Sweden at the end of September 2014.

* wholesale prices in Finland, Sweden and the Baltic countries.
** IMS Health Market Prognosis 2013-2017


Operating Environment 2013

Sweden

  • Size of markets
    ~3.5 EUR billion
  • Market growth -1.4%
  • Wholesale market
    position 2
  • Retail market position 3

Finland

  • Size of markets
    ~2 EUR billion
  • Market growth 1.8%
  • Wholesale market
    position 2

Baltics

  • Size of markets
    ~1 EUR billion